Shane Lafayette

Shane Lafayette is a seasoned business development professional currently serving as Senior Director at Innoviva Specialty Therapeutics, Inc., where responsibilities include overseeing strategic initiatives for an integrated biopharma platform. Prior experience includes a role as Director of Corporate Development at Centessa Pharmaceuticals, focusing on strategic partnerships and corporate financing. At Arvelle Therapeutics, Shane contributed to a significant acquisition and led efforts for acquiring international rights to neuro assets as Associate Director of Corporate Development. Additionally, Shane held positions in finance and commercial strategy at Axovant Gene Therapies and Bracco, along with earlier roles in financial analysis at LifeCell. Shane holds an MBA from NYU Stern School of Business, a BSBA in Finance from Thomas Edison State University, and an AS in Business Administration and Management from Raritan Valley Community College.